The objective of this study was to estimate the health service use and costs resulting from the introduction of the interRAI Minimum Data Set-Home Care (MDS-HC) assessment compared with usual assessment.A randomised controlled trial of elderly people in New Zealand measured the use and cost of prescribed and delivered (4 months post-assessment) health services of 153 participants assessed using the standard [Needs Assessment and Service Co-ordination (NASC)] tool,and 158 participants assessed using the MDS-HC. The results suggest that the MDS-HC resulted in more prescribed personal health and community services, and less disability support services than with NASC. The cost of prescribed services was significantly greater for the MDS-HC (NZ$1840) than the NASC (NZ$1522, P < 0.001). The cost of delivered services was significantly greater for the MDS-HC (NZ$4809)than the NASC (NZ$2727, P < 0.001), including higher costs of hospitalizations (NZ$2523 vs. NZ$1112, P= 0.257). There were pronounced differences among 'low-need' compared with 'high-need'elderly people. These results suggest that the interRai assessment tool resulted in greater cost of prescribed preventive services and less prescribed disability services than the NASC. However, differences in delivered services were driven primarily by differences in hospitalizations. The results highlight the importance of integrating the assessment procedure with the delivery of health services, but suggest that further study is warranted. The results have implications for purchasers of health services for elderly people.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-2524.2009.00855.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Determining safety, usability, acceptability and potential for clinical use of an innovative walking frame design with in- and community patients.
Disabil Rehabil Assist Technol
January 2025
Centre for Human Movement and Rehabilitation, School of Health & Society, University of Salford, Salford, Greater Manchester, UK.
Purpose: Falls cost the NHS over £2 billion a year, with incidence increasing rapidly with age. Design of indoor walking frames remains limited, often needing to be lifted and not supporting sit-to-stand and turning manoeuvres, which can lead to falling. This study explored aspects of safety and satisfaction and potential for clinical use of a novel prototype walking frame.
View Article and Find Full Text PDFQuality of hypertension management and health insurance impact: an assessment of insured and uninsured patients with systemic hypertension in a teaching Hospital in Ilorin, Nigeria.
Malawi Med J
January 2025
Department of Epidemiology and Community Health, University of Ilorin and University of Ilorin Teaching Hospital, Nigeria.
Background: Patient satisfaction is an important indicator used to measure quality of care and the performance of healthcare services. This study assessed patient satisfaction with the quality of hypertension care received by both insured and uninsured patients with systemic hypertension.
Methods: This comparative cross-sectional study was conducted among insured and uninsured patients with systemic hypertension attending the Medical Outpatient Department clinics of the University of Ilorin Teaching Hospital, Kwara State, Nigeria, from May to July, 2023.
Cost savings of reducing opioid prescribing for the treatment of people with low back pain in general practice: a modelling study.
Lancet Reg Health West Pac
January 2025
School of Public Health, Faculty of Medicine and Health, University of Sydney, NSW, 2006, Australia.
Background: Low back pain (LBP) is the leading cause of disability worldwide. Contrary to clinical guidelines, opioids are frequently prescribed early in the management of LBP in primary care, leading to potential harm and downstream healthcare costs. The objective of this study was to model the one-year impacts of strategies that reduce opioid prescribing for low back pain (LBP) in primary care on healthcare costs and overdose deaths Australia-wide and explore the potential for such strategies to be cost-neutral.
View Article and Find Full Text PDFAntithrombotic therapy following lower extremity endovascular revascularization: The results of a survey of vascular specialists.
JVS Vasc Insights
October 2024
Division of Vascular Surgery, University of Pittsburgh.
Objective: Antithrombotic therapy improves endovascular intervention outcomes for peripheral artery disease. However, there are limited data guiding the choice and duration of these adjuvant therapies. Thus, we explored current antithrombotic prescribing preferences among vascular interventionalists, hypothesizing that there are varied and inconsistent treatment practices among providers.
View Article and Find Full Text PDFVery Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung Cancer.
Pharmacoecon Open
January 2025
Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Objectives: Immune checkpoint inhibitor (ICI)-containing treatment is currently prescribed as first-line treatment for all patients with advanced non-small cell lung cancer (NSCLC) without targetable driver mutations. However, only 30-45% of patients show no progression within 12 months after treatment start. Various biomarkers are being studied to save costly and potentially harmful treatment in non-responders.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!